156
Participants
Start Date
January 1, 2014
Primary Completion Date
July 1, 2015
Study Completion Date
September 1, 2015
EVARREST™ Fibrin Sealant Patch
Topical hemostat
Clinical Investigation Site #73, Sydney
Clinical Investigation Site #72, Camperdown
Clinical Investigation Site #70, Melbourne
Clinical Investigation Site #71, Brisbane
Clinical Investigation Site #74, Bedford Park
Clinical Investigation Site #40, Ghent
Clinical Investigation Site #12, New York
Clinical Investigation Site #20, Philadelphia
Clinical Investigation Site #21, Bethesda
Clinical Investigation Site #16, Baltimore
Clinical Investigation Site #15, Atlanta
Clinical Investigation Site #14, Indianapolis
Clinical Investigation Site #17, St Louis
Clinical Investigation Site #18, Houston
Clinical Investigation Site #10, Paterson
Clinical Investigation Site #82, Kanagawa
Clinical Investigation Site #81, Saitama
Clinical Investigation Site #80, Osaka
Clinical Investigation Site #33, Bristol
Clinical Investigation Site #35, Cottingham
Clinical Investigation Site #34, Manchester
Clinical Investigation Site #32, Aberdeen
Clinical Investigation Site #31, Clydebank
Clinical Investigation Site #30, Edinburgh
Ethicon, Inc.
INDUSTRY